Read More Pharma Industry News Semaglutide shows significant vascular benefits in PAD patients with type 2 diabetes, STRIDE trial confirms Semaglutide improves walking capacity and reduces disease progression in PAD patients with type 2 diabetes, STRIDE trial results reveal at ADA 2025. byPallavi MadhirajuJune 22, 2025